davidnovosardian

My CRVS Price Targets

Viés de alta
NASDAQ:CRVS   Corvus Pharmaceuticals, Inc.
Hello all,

As you all may have noticed from doing your research that there has been a quantifiable spike in insider buying by the President and Director of Orbimed Advisors.

On February 17th, 2021 there was an Initial Public Offering at $3.50/share.

I have not made any extensive due diligence on the company yet, solely interested in the high amount of shares bought up by insiders.

Thank you
Aviso legal

As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.